---
title: "Cassava Sciences, Inc. (SAVA.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/SAVA.US.md"
symbol: "SAVA.US"
name: "Cassava Sciences, Inc."
industry: "制藥"
---

# Cassava Sciences, Inc. (SAVA.US)

| Item | Detail |
|------|--------|
| Industry | 制藥 |
| Location | 美股市場 |
| Website | [www.cassavasciences.com](https://www.cassavasciences.com) |

## Company Profile

卡薩瓦科學公司（Cassava Sciences, Inc.）是一家臨床階段的生物技術公司，專注于開發神經退行性疾病的藥物。其主要治療產品候選藥物是 simufilam，這是一種小分子藥物，已完成第二階段臨床試驗；而其研究性診斷產品候選藥物是 SavaDx，這是一種基于血液的生物標志物/診斷工具，用于檢測阿爾茨海默病。卡薩瓦科學公司之前被稱為疼痛治療公司（Pain Therapeutics, Inc.）

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.97 | 101/257 | - | - | - |
| PB | 1.26 | 60/257 | 1.66 | 1.15 | 0.76 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-11-12T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.13 |
| Highest Target | 8.00 |
| Lowest Target | 8.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/SAVA.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/SAVA.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/SAVA.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.